Aberrant accumulation of TMEM43 accompanied by perturbed transmural gene expression in arrhythmogenic cardiomyopathy. Issue 11 (21st October 2021)

• Record Type: Journal Article
• Authors: Shinomiya, Haruki; Kato, Hisakazu; Kuramoto, Yuki; Watanabe, Nozomi; Tsuruda, Toshihiro; Arimura, Tadaaki; Miyashita, Yohei; Miyasaka, Yoshiki; Mashimo, Tomoji; Takuwa, Ayako; Motooka, Daisuke; Okuzaki, Daisuke; Matsuoka, Ken; Tsukamoto, Osamu; Hakui, Hideyuki; Yamada, Noriaki; Lee, Jong‐Kook; Kioka, Hidetaka; Kitakaze, Masafumi; Takashima, Seiji; Sakata, Yasushi; Asano, Yoshihiro
• Is Part Of: FASEB journal. Volume 35:Issue 11(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-10-21
• Subjects: arrhythmogenic right ventricular dysplasia -- glycosylation -- TMEM43 protein; Biology -- Periodicals; Biology, Experimental -- Periodicals; 570
• DOI: 10.1096/fj.202100800R
• Languages: English
• ISSNs: 0892-6638

Abstract

Abstract: Arrhythmogenic cardiomyopathy (ACM) caused by TMEM43 p.S358L is a fully penetrant heart disease that results in impaired cardiac function or fatal arrhythmia. However, the molecular mechanism of ACM caused by the TMEM43 variant has not yet been fully elucidated. In this study, we generated knock‐in (KI) rats harboring a Tmem43 p.S358L mutation and established induced pluripotent stem cells (iPSCs) from patients based on the identification of TMEM43 p.S358L variant from a family with ACM. The Tmem43 ‐S358L KI rats exhibited ventricular arrhythmia and fibrotic myocardial replacement in the subepicardium, which recapitulated the human ACM phenotype. The four‐transmembrane protein TMEM43 with the p.S358L variant (TMEM43 S358L ) was found to be modified by N‐linked glycosylation in both KI rat cardiomyocytes and patient‐specific iPSC‐derived cardiomyocytes. TMEM43 S358L glycosylation increased under the conditions of enhanced endoplasmic reticulum (ER) stress caused by pharmacological stimulation or age‐dependent decline of the ER function. Intriguingly, the specific glycosylation of TMEM43 S358L resulted from the altered membrane topology of TMEM43. Moreover, unlike TMEM43 WT, which is mainly localized to the ER, TMEM43 S358L accumulated at the nuclear envelope of cardiomyocytes with the increase in glycosylation. Finally, our comprehensive transcriptomic analysis demonstrated that the regional differences in gene expression patterns between the inner and outer layers observed in the wild type myocardium were partially diminished in the KI myocardium prior to exhibiting histological changes indicative of ACM. Altogether, these findings suggest that the aberrant accumulation of TMEM43 S358L underlies the pathogenesis of ACM caused by TMEM43 p.S358L variant by affecting the transmural gene expression within the myocardium.